Cargando…
New and emerging therapies for the treatment of rheumatoid arthritis
The introduction of tumor necrosis factor (TNF) inhibitors in the late 1990s significantly changed the therapeutic approach for rheumatoid arthritis (RA). With the approval of subsequent TNF inhibitors as well as other biologic agents effective in the management of RA, the treatment paradigm has bec...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074771/ https://www.ncbi.nlm.nih.gov/pubmed/27789996 |
| _version_ | 1782461771306500096 |
|---|---|
| author | Feely, Michael G |
| author_facet | Feely, Michael G |
| author_sort | Feely, Michael G |
| collection | PubMed |
| description | The introduction of tumor necrosis factor (TNF) inhibitors in the late 1990s significantly changed the therapeutic approach for rheumatoid arthritis (RA). With the approval of subsequent TNF inhibitors as well as other biologic agents effective in the management of RA, the treatment paradigm has become increasingly complex. This review examines the current literature regarding the efficacy and toxicity of these and other new anti-rheumatic therapies and discusses effective therapeutic strategies for their use. |
| format | Online Article Text |
| id | pubmed-5074771 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50747712016-10-27 New and emerging therapies for the treatment of rheumatoid arthritis Feely, Michael G Open Access Rheumatol Review The introduction of tumor necrosis factor (TNF) inhibitors in the late 1990s significantly changed the therapeutic approach for rheumatoid arthritis (RA). With the approval of subsequent TNF inhibitors as well as other biologic agents effective in the management of RA, the treatment paradigm has become increasingly complex. This review examines the current literature regarding the efficacy and toxicity of these and other new anti-rheumatic therapies and discusses effective therapeutic strategies for their use. Dove Medical Press 2010-07-24 /pmc/articles/PMC5074771/ /pubmed/27789996 Text en © 2010 Feely, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
| spellingShingle | Review Feely, Michael G New and emerging therapies for the treatment of rheumatoid arthritis |
| title | New and emerging therapies for the treatment of rheumatoid arthritis |
| title_full | New and emerging therapies for the treatment of rheumatoid arthritis |
| title_fullStr | New and emerging therapies for the treatment of rheumatoid arthritis |
| title_full_unstemmed | New and emerging therapies for the treatment of rheumatoid arthritis |
| title_short | New and emerging therapies for the treatment of rheumatoid arthritis |
| title_sort | new and emerging therapies for the treatment of rheumatoid arthritis |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074771/ https://www.ncbi.nlm.nih.gov/pubmed/27789996 |
| work_keys_str_mv | AT feelymichaelg newandemergingtherapiesforthetreatmentofrheumatoidarthritis |